Stay updated on NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial
Sign up to get notified when there's something new on the NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial page.

Latest updates to the NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial page
- Check6 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3. The related topics 'Schizophrenia' and 'MedlinePlus Genetics' were removed.SummaryDifference0.2%

- Check13 days agoChange DetectedAdded related topic links for Schizophrenia and MedlinePlus Genetics on the page. This is a minor metadata enhancement that does not change core study details or functionality.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRemoved the primary condition label 'Schizophrenia' and related topics including 'MedlinePlus Genetics' from the page.SummaryDifference0.2%

- Check34 days agoChange DetectedAdded Revision: v3.4.2; removed the lapse-in-government-funding notice and the prior Revision: v3.4.1 from the page.SummaryDifference0.4%

- Check41 days agoChange DetectedThe page now includes a government funding lapse notice with status update and links to cc.nih.gov and opm.gov, and adds related topics such as Schizophrenia and MedlinePlus Genetics, while updating the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check48 days agoChange DetectedAdded a glossary toggle and updated metadata fields (Last Update Submitted that Met QC Criteria, Revision: v3.4.0) while removing some related topics and older QC items (Schizophrenia, MedlinePlus Genetics, No FEAR Act data, Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial page.